Skip to content

A prospective cohort study for the association of pretransplant iron overload with infection and outcome after allogeneic hematopoietic stem cell transplantation (F-STUDY)

A prospective cohort study for the association of pretransplant iron overload with infection and outcome after allogeneic hematopoietic stem cell transplantation (F-STUDY) - A prospective study for the association of pretransplant iron overload with infection after allogeneic HSCT (F-STUDY)

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000003460
Enrollment
200
Registered
2010-04-07
Start date
2010-03-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

AML,ALL,MDS

Interventions

None listed

Sponsors

Kanto Study Group for Cell Therapy
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1.Patients with acute leukemia or myelodysplastic syndrome 2.The first time of allogeneic HSCT (no limitation of stem cell source, or HLA disparity) 3.20-y.o or older 4.No limitation of conditioning regimen, GVHD prophylaxis and supportive therapy

Exclusion criteria

Exclusion criteria: 1.Past history of allogeneic HSCT 2.Without written informed concent

Design outcomes

Primary

MeasureTime frame
Infection during 100 days after HSCT (pathogens, organs and cumulative incidence)

Secondary

MeasureTime frame
Day 100 nonrelapse mortality 1-y nonrelapse mortality 1-y overall survival

Countries

Japan

Contacts

Public ContactMasatsugu Tanaka

Kanto Study Group for Cell Therapy Trial Office

tanakam@yokohama-cu.ac.jp045-520-2222

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026